Here we count down the top five tweets from @EPM_magazinethat have gained the most impressions this week, taken from Twitter analytics.
5. Guiding you through how to best prepare for the impact of big data in healthcare, Manuel Duval’s (Scientist.com) latest article makes it onto our list at number five.
Reducing the odds — how to prepare for the impact of big data
4. In fourth place is the recent article from SEA Vision on the benefits of aggregation and how in combination with serialisation it can be most beneficial to pharma companies.
Weighing it up… why aggregation is worth the consideration
3. Disrupt or be disrupted? Our latest article from DHL Supply Chain makes it onto our Top Five at number three.
Disrupt or be disrupted? Why blockchain will change your world
2. This week’s runner up position goes to the announcement that the FDA has accepted the supplemental new drug application for Novartis’ Promacta.
FDA accepts supplemental new drug application for Promacta and grants it priority review
1. Number one this week goes to the news that UK biotech, Orbit Discovery, closed its series A financing round, raising £6.9 million to expand its platform.